Technology | June 13, 2011

Multi-Tracer Platform Expands Cassette-Based Tracer Production to FDG Citrate Formulation

June 13, 2011 - Expanding upon its radiopharmacy platform, GE Healthcare is introducing new tracers to the FASTlab multi-tracer platform, an advanced positron emission tomography (PET) chemistry system on which the company is also developing PET proprietary agents. The system offers a number of significant enhancements to address the ever-evolving challenges of tracer production. With the addition of three new cassettes, users can access and produce FDG phosphate formulation, NaF, FMISO (HPLC free), FLT (HPLC free) and FDG citrate formulation (equivalent to Tracerlab MX standard formulation) on the same platform.

To facilitate regulatory preparation work, DMF type V, describing the platform, and DMF type II, outlining tracer cassette and synthesis, have been filed with the FDA.

FASTlab is an open-ended platform capable of accommodating new tracers as they are developed, eliminating the need to buy a dedicated synthesis module to process a different tracer. The innovative hardware and user-interface allows for consecutive production of different tracers on the same module. Clinicians just need to swap the cassette and the system is ready for the next tracer. Cassettes are barcoded — when loaded into the system, the processor reads the barcode and automatically downloads the right production parameters and batch information, helping customers achieve CFR 212 cGMP compliance. FASTlab is also a key component of Tracercenter, one source and one complete solution for enabling compliant PET tracer production.

For more information: www.gehealthcare.com

Related Content

News | Radiopharmaceuticals and Tracers

August 2, 2019 — The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) ...

Home August 02, 2019
Home
News | Radiopharmaceuticals and Tracers

July 16, 2019 – NorthStar Medical Radioisotopes LLC announced completion of construction on its 20,000-square-foot ...

Home July 16, 2019
Home
News | Radiopharmaceuticals and Tracers

June 5, 2019 – BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel ...

Home June 05, 2019
Home
News | Radiopharmaceuticals and Tracers

May 17, 2019 — Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular ...

Home May 17, 2019
Home
News | Radiopharmaceuticals and Tracers | Jeff Zagoudis, Associate Editor

May 10, 2019 — Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in ...

Home May 10, 2019
Home
News | Radiopharmaceuticals and Tracers

October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc. (CORAR) — the voice of the radionuclide ...

Home October 12, 2018
Home
Feature | Radiopharmaceuticals and Tracers | Dave Fornell

February 8, 2018 — The U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC) recently took ...

Home February 26, 2018
Home
News | Radiopharmaceuticals and Tracers

August 30, 2017 — ARTMS Products Inc. signed a strategic partnership with GE Healthcare around ARTMS’ proprietary ...

Home August 30, 2017
Home
News | Radiopharmaceuticals and Tracers

May 22, 2017 — Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced the ...

Home May 22, 2017
Home
News | Radiopharmaceuticals and Tracers

April 28, 2017 — Researchers at the Australian Nuclear Science and Technology Organisation (ANSTO) have led the ...

Home April 28, 2017
Home
Subscribe Now